Hypocomplementemia in systemic sclerosis

Reumatismo

Volumn 61, Issue 2, 2009, Pages 156-157

  Hudson, M ^a   Steele, R ^a   Lu, Y ^a  

^a Canadian Scleroderma Research Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; COMPLEMENT; DNA TOPOISOMERASE; BIOLOGICAL MARKER;

CANADA; CLINICAL TRIAL; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEFICIENCY; DISABILITY SEVERITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; BLOOD; FEMALE; HOSPITALIZATION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NOTE; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 68149163532     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Cuomo G, Abignano, G, Ruocco L, Vettori S, Valentini G. Hypocomplementemia in systemic sclerosis. Reumatismo 2008; 60 (4): 268-73.
2. Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M. Hypocomplementemia in systemic sclerosis - clinical and serological correlations. J Rheumatol 2007; 34 (11): 2218-23.
3. Fritzler MJ, McCarty GA, Ryan JP, Kinsella TD. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arthritis Rheum 1983; 26: 140-5.
4. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35 (1): 35-42.